| Literature DB >> 30402571 |
Joon Se Jung1, Chang Hee Han1, Sangrak Bae1.
Abstract
Purpose: We aimed to analyze the incidence and prevalence of urolithiasis in Korea over the last decade using the National Health Insurance (NHI) sample cohort data. Materials andEntities:
Keywords: Incidence; Prevalence; Urolithiasis
Mesh:
Year: 2018 PMID: 30402571 PMCID: PMC6215783 DOI: 10.4111/icu.2018.59.6.383
Source DB: PubMed Journal: Investig Clin Urol ISSN: 2466-0493
Fig. 1Structure of the National Health Insurance-Standard cohort database (DB).
Definition and total number of diagnosis, incidence rate (per 1,000 person-year) by diagnostic codes
| ICD code | Definition | Total number | Incidence rate | ||
|---|---|---|---|---|---|
| Male | Female | Male | Female | ||
| N13.2 | Hydronephrosis with renal and ureteral calculous obstruction | 1,503 | 877 | 0.26 | 0.15 |
| N20.0 | Calculus of kidney | 5,746 | 3,702 | 1.00 | 0.64 |
| N20.1 | Calculus of ureter | 18,084 (58.2) | 10,220 (54.3) | 3.20 | 1.79 |
| N20.2 | Calculus of kidney with calculus of ureter | 1,253 | 744 | 0.22 | 0.13 |
| N20.9 | Urinary calculus, unspecified | 2,446 | 1,895 | 0.43 | 0.33 |
| N20a | Calculus of kidney and ureter | 2,040 | 1,400 | 0.36 | 0.24 |
| Total | 31,072 | 18,838 | 5.46 | 3.29 | |
Values are presented as number only or number (%).
ICD, international classification of diseases.
a:N20 code is no longer used nowadays due to its unspecific definition.
Fig. 2Incidence of urolithiasis in patients by 5-year age group.
Comparison of incidence rates by age group
| Age group | Male | Female | ||||
|---|---|---|---|---|---|---|
| Observation period (person-years) | No. of occurrence | Incidence rate (/1,000 person-year) | Observation period | No. of occurrence | Incidence rate (/1,000 person-year) | |
| 0 | 304,738 | 6 | 0.02 | 284,304 | 1 | 0.00 |
| 1–4 | 275,141 | 21 | 0.08 | 250,678 | 8 | 0.03 |
| 5–9 | 420,066 | 47 | 0.11 | 378,284 | 36 | 0.10 |
| 10–14 | 420,987 | 144 | 0.34 | 374,213 | 97 | 0.26 |
| 15–19 | 381,872 | 493 | 1.29 | 350,630 | 327 | 0.93 |
| 20–24 | 455,724 | 830 | 1.82 | 454,817 | 606 | 1.33 |
| 25–29 | 437,824 | 1,717 | 3.92 | 433,679 | 749 | 1.73 |
| 30–34 | 518,300 | 2,461 | 4.75 | 511,558 | 1,077 | 2.11 |
| 35–39 | 490,942 | 2,761 | 5.62 | 483,271 | 1,285 | 2.66 |
| 40–44 | 501,996 | 2,885 | 5.75 | 491,071 | 1,521 | 3.10 |
| 45–49 | 411,564 | 2,911 | 7.07 | 404,737 | 1,809 | 4.47 |
| 50–54 | 286,072 | 2,575 | 9.00 | 290,160 | 1,804 | 6.22 |
| 55–59 | 226,695 | 1,870 | 8.25 | 241,595 | 1,564 | 6.47 |
| 60–64 | 201,851 | 1,483 | 7.35 | 240,441 | 1,244 | 5.17 |
| 65–69 | 143,085 | 1,107 | 7.74 | 193,778 | 954 | 4.92 |
| 70–74 | 77,326 | 687 | 8.88 | 137,453 | 637 | 4.63 |
| 75–79 | 38,621 | 338 | 8.75 | 81,475 | 360 | 4.42 |
| 80–84 | 18,243 | 138 | 7.56 | 45,025 | 166 | 3.69 |
| ≥85 | 6,584 | 56 | 8.51 | 21,022 | 82 | 3.90 |
Fig. 3Gender incidence by ages.
Fig. 4Number of patients by year.
Fig. 5Incidence rate of 16 major administrative districts.
Fig. 6Prevalence analysis. (A) Total prevalence by year in each sex. (B) Comparison between prevalence rates in total, male and female.